Adoptive transfer of dendritic cells modulates immunogenesis and tolerogenesis in a neonatal model of murine cutaneous leishmaniasis by Ponce, Loida V et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Kinetoplastid Biology and Disease
Open Access Original research
Adoptive transfer of dendritic cells modulates immunogenesis and 
tolerogenesis in a neonatal model of murine cutaneous 
leishmaniasis
Loida V Ponce†1, José Corado†2, Nilka L Díaz1 and Felix J Tapia*1
Address: 1Laboratorio de Biología Molecular, Instituto de Biomedicina, Universidad de Central Venezuela, Apartado 4043, Caracas 1010A, 
Venezuela and 2Departamento de Ciencias Fisiológicas, Universidad de Carabobo, Valencia, Venezuela
Email: Loida V Ponce - lponce@thor.uc.edu.ve; José Corado - jcorado@uc.edu.ve; Nilka L Díaz - nilkadiaz@hotmail.com; 
Felix J Tapia* - ftapia@telcel.net.ve
* Corresponding author    †Equal contributors
Abstract
We evaluated the adoptive transfer of DCs on Leishmania (L.) mexicana-infected neonatal BALB/c
mice. DCs were isolated and purified from the spleens of the following donor groups: a) Adult
BALB/c mice infected during adulthood with L. (L) mexicana; b) Adult BALB/c mice infected during
neonatal life; c) Healthy neonatal BALB/c mice; d) Healthy adult BALB/c mice. A neonatal model of
infection, generated after inoculation with 5 × 105 promastigotes of L. (L) mexicana, was used as the
infection control group. Sixteen hours after intraperitoneal transfer of DCs (1 × 103, 1 × 105, or 1
× 106 cells/ml), neonatal recipient BALB/c mice were infected. The adoptive transfer of DCs
diminished disease progression in neonatal mice. This reduction depends on the quantity and
provenance of transferred DCs, since the effect was more evident with high numbers of DCs from
adult mice infected during adulthood and healthy neonatal mice. Protection was significantly
reduced in animals receiving DCs from healthy adult mice but it was absent in mice receiving DCs
from adult mice infected during neonatal life. These results suggest that genetic susceptibility to
Leishmania infection can be modified during neonatal life, and that the period of life when antigens
are encountered is crucial in influencing the capacity of DCs to induce resistance or tolerance.
Background
Medawar et al. [1] showed almost half a century ago that
rodents injected at birth with splenocytes from genetically
different donors could accept transplants from that donor
as an adult. These milestone experiments guided the
notion that the introduction of antigens during neonatal
life leads to tolerance and that the immune system func-
tions by making a distinction between self and nonself.
For some years, Matzinger et al. have persevered on the
hypothesis that tolerance is not an intrinsic property of
the newborn immune system [2,3]. For example, many
studies have shown that neonatal exposure to antigen
may prime T cells and induce both Th1 and Th2 cells [4-
7]. Moreover, Adkins et al. have demonstrated that
although neonates develop compartmentally distinct pri-
mary responses to antigen immunization (mixed Th1/
Th2 in lymph nodes and Th2 in spleen), after rechallenge
the elicited secondary response is always of the Th2 type
[7,8]. They have also proved that even in the lymph
nodes, the Th2 function persists for a prolonged period
after a single immunization, and that animals initially
immunized as neonates are impaired in their capacity to
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develop the expected Th1 memory effector function
observed in adults [9]. The biased immunogenic neonatal
immunity may be attributable to factors associated with
antigen presentation such as type of antigen-presenting
cell, accompanying adjuvant and the nature, concentra-
tion and in vivo availability of the antigen [5,10-13]. Rest-
ing T cells need two signals to be activated; signal 1 from
TCR binding to MHC/peptide and signal 2 (co-stimula-
tion) from a professional phagocyte, such as a dendritic
cell or a macrophage. Tolerance is associated to a lack of
co-stimulation that usually occurs when antigen is
encounter by a non-professional phagocyte, or by profes-
sional phagocytes in a non-APC tissue (lymphoid tissue,
skin, etc)[14]. In this study, we have evaluated the effect
of adoptive transfer of DCs from adult and neonatal mice
infected with L. (L.) mexicana, and from healthy adult and
neonatal mice. As in the L. major mouse model, we have
shown that infection with L. (L.) mexicana strain MHOM/
BZ/82/BEL21, generates a Th1 response associated to pro-
tective immunity in C57BL/6 mice, and a Th2 response
related to non-healing disease in BALB/6 mice [15].
Leishmaniasis is an excellent model to study the extremes
of host/parasite relationships, particularly the diversity of
the immune response associated to the genetic back-
ground of the host. In addition, mice can reproduce the
distinct clinical forms observed in humans [16,17]. These
models have been particularly important to show that
skin-derived DCs including Langerhans cells play an
important role in cutaneous leishmaniasis, where they
can transport Leishmania antigens to the lymph nodes and
induce specific immune responses [18-24]. Moll et al.
have also shown that Langerhans cells may act as reser-
voirs sustaining parasite-specific stimulation of T memory
cells, thus protecting animals from reinfection [25].
Results and Discussion
Establishment of a L. (L.) mexicana infection model in 
neonatal BALB/c mice
The progress of L. (L.) mexicana infection in neonatal
BALB/c mice, after the inoculation with 5 × 104, 1 × 105, 2
× 105 or 5 × 105 promastigotes was determined by meas-
uring the footpad thickness during 6 weeks. All 4 experi-
mental groups developed lesions. Mice that received 1 ×
105, 2 × 105  and 5 × 105  promastigotes respectively,
showed a significant increase (p ≤ 0.05) on footpad thick-
ness starting from the second week, reaching a maximal
value on the sixth week of evaluation (Fig. 1A). This
increase in footpad thickness was much greater (p ≤ 0.05)
in the group inoculated with 5 × 105 promastigotes, with
lesions appearing from the first week (Fig. 1A). Moreover,
this experimental group presented a similar evolution to
that observed in L. (L.) mexicana-infected adult BALB/c
mice inoculated with 1 × 106 promastigotes (Fig. 1B). The
statistical analysis using a Wilcoxon matched-pairs
signed-ranks test of the percentage increase from the start-
ing footpad thickness in both neonatal and adult BALB/c
mice infected with 5 × 105 and 1 × 106 promastigotes,
respectively, showed a significant (p ≤ 0.05) two-tailed
value and a very significant Spearman correlation (r =
1.000, p = 0.0014). The starting footpad thickness in neo-
Progression of L. (L.) mexicana infection in neonatal BALB/c mice Figure 1
Progression of L. (L.) mexicana infection in neonatal BALB/c mice. A. Footpad thickness of adult mice infected with 1 × 106 pro-
mastigotes (■ ), non-infected mice (❍ ), neonatal mice infected with 5 × 104 promastigotes (), neonatal mice infected with 1 × 
105 promastigotes (▲ ), neonatal mice infected with 2 × 105 promastigotes () and neonatal mice infected with 5 × 105 promas-
tigotes (● ). B. Percentage increase from the starting footpad thickness in both neonatal () and (■ ) adult BALB/c mice 
infected with 5 × 105 and 1 × 106 promastigotes, respectively.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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natal and adult BALB/c mice was 1.67 mm and 1.85 mm,
respectively.
We used 5 × 105 promastigotes as the optimal concentra-
tion for L. (L.) mexicana infection in all the subsequent
experiments including the infection control group. This
neonatal murine model of L. (L.) mexicana infection used
half the numbers of promastigotes previously described to
infect adult BALB/c mice [16]. A significant Spearman cor-
relation attested that our neonatal model was comparable
to the adult model of infection. Although infected neona-
tal mice have a statistically similar clinical outcome that
infected adult mice, we ignore whether these mice have
similar level of infection and therefore similar concentra-
tions of antigens carried over by the transferred DCs, how-
ever, looking at the present results one can speculate that
DCs from mice infected during neonatal life induced tol-
erance probably due to a high parasite burden, and not a
lack of adjuvancity since DCs from healthy neonatal mice
were able to partially protect against Leishmania infection.
Other studies have shown a similar pattern of Th2-biased
immune response in other models of neonatal infection
[7,11]. We also observed that even after the inoculation of
considerable numbers of parasites, neonatal mice differed
significantly from adult mice in their percentage incre-
ment from the starting footpad thickness, suggesting a
functional impairment of the primary immune response.
This may be explained, first by the fact that in BALB/c mice
carry a point mutation in the Nramp1 (natural-resistance-
associated macrophage protein) gene that allows the
mRNA degradation of macrophage activation genes,
increasing susceptibility to Leishmania infection [26]. Sus-
ceptibility associated with the dominant expression of the
costimulatory molecule CD86 (B7-2) and the subsequent
generation of the Th2-mediated response [27-31]. Sec-
ond, the proof that murine naïve neonatal T cells, unlike
adult T cells, express a Th2 phenotype and are highly defi-
cient in Th1 functions [32,33].
Morphological and immunophenotypic characterization 
of murine splenic dendritic cells
DCs obtained by our purification method showed charac-
teristic dendritic cell morphology, and a 97% purity as
determined by CD11c immunostaining and flow cytome-
try. A minor fraction of about 3.5 % expressed CD3 and
NK1.1 (Fig. 2). The expression of CD11c, MHC-II and
CD86 molecules was detected by immunocytochemistry,
thus demonstrating that these cells showed characteristics
of functionally mature DCs.
Splenic DCs were isolated for our adoptive transfer exper-
iments since they are mobile antigen-presenting cells that
migrate to peripheral lymph organs where they stimulate
naive T cells, thus initiating primary T cell responses [34-
36]. Further, splenic DCs have been isolated by standard-
ized procedures based on the high expression of CD11c
and the lack of CD205 [37].
Progression of the infection in neonatal recipient BALB/c 
mice after adoptive transfer of dendritic cells from the 
distinct experimental groups
The adoptive transfer of 1 × 103, 1 × 105 or 1 × 106 DCs
from adult BALB/c mice infected during adulthood with L.
(L) mexicana on neonatal recipient mice modified the
course of infection, showing a delayed lesion growth from
the second week onward (Fig. 3) as compared with the
infection control group. This reduction in footpad thick-
ness was dependent of DC numbers, since at the highest
concentration of 1 × 106, lesions were smaller than those
observed with 1 × 103 and 1 × 105 DCs from the fifth week
onward (Fig. 3). At the seventh week of infection, lesion
size decreased by 40% after the adoptive transfer of 1 ×
106 DCs, whereas in animals inoculated with 1 × 105 and
1 × 103 DCs the decrease was of 33% and 22%, respec-
tively. In contrast, the adoptive transfer of 1 × 105or 1 ×
106 DCs from adult BALB/c mice infected during neonatal
life with L. (L) mexicana fail to modify the course of infec-
tion of neonatal recipient BALB/c mice as compared with
infection control animals (Fig. 4). However, those mice
receiving 1 × 106 DCs showed a significant reduction in
lesion growth (p ≤ 0.05) on weeks 2, 3 and 4. This effect
disappeared from the fifth week onwards (Fig. 4).
Frequency distributions of purified dendritic cells labelled  CD11c-FITC showing 97.17% purity (right), and FITC-iso- type control (IgG1) (left) Figure 2
Frequency distributions of purified dendritic cells labelled 
CD11c-FITC showing 97.17% purity (right), and FITC-iso-
type control (IgG1) (left). The information shown is from a 
single cell isolation procedure, representative of various sep-
arate experiments.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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Moreover, the adoptive transfer of 1 × 105 or 1 × 106 DCs
from healthy adult BALB/c mice modified the course of
infection in neonatal recipient mice, showing a delayed
and significant decrease (p ≤ 0.05) in lesion growth from
the second week of infection (Fig. 5). This reduction in
footpad thickness was dependent on DC numbers, since
at 1 × 106 lesions were significantly (p ≤ 0.05) smaller
than those observed in mice transferred with 1 × 105 DCs,
which also initiated their lesions on the third week (Fig.
5). At the seventh week of infection, lesion size decreased
by 30% after the adoptive transfer of 1 × 106 DCs and by
10% in mice receiving 1 × 105 DCs. similarly, the adoptive
transfer of 1 × 103 or 1 × 105 DCs from healthy neonatal
BALB/c mice modified the course of infection of neonatal
recipient mice, showing a delayed and significant decrease
(p ≤ 0.05) in lesion growth from the second week of infec-
tion. This reduction in footpad thickness was very similar
in both tested concentrations (Fig. 6). At the seventh week
of infection, lesion size decreased by 35% in both groups.
Disease progression was substantially decreased after
transferring cells from adult BALB/c mice infected during
adulthood with L. (L) mexicana, healthy adult BALB/c
mice and healthy neonatal BALB/c mice. The reduction in
these 3 groups was statistically significant (p ≤ 0.05) as
compared with the infection control group. This reduc-
tion in footpad thickness was absent or considerably
diminished in mice receiving DCs from adult BALB/c
mice infected during neonatal life with L. (L) mexicana
(Fig. 7).
Our results showed that the preceding intraperitoneal
adoptive transfer of DCs diminished the progression of L.
(L.) mexicana infection in neonatal BALB/c recipient mice.
These results contrast with those of Moll and Berberich
[38] showing that only intravenous administration of
antigen-pulsed Langerhans cells, but not intradermal or
intraperitoneal inoculation, induced resistance against
Leishmania infection. In this study, the observed protec-
tion depends on the quantity and provenance of the trans-
ferred DCs, since the effect was more evident with high
cellular numbers of DCs from adult BALB/c mice infected
during adulthood and healthy neonatal mice, where
lesions were about 40% smaller than in the infection con-
trol group. DCs from these two groups have the intrinsic
capacity to induce protective or resistant immune
responses very early in life. That neonatal DCs appear to
be more protective, on a per cell basis, than adults DCs is
Progression of infection in neonatal recipient BALB/c mice  after adoptive transfer of DCs from adult BALB/c mice  infected during adulthood with L. (L) mexicana Figure 3
Progression of infection in neonatal recipient BALB/c mice 
after adoptive transfer of DCs from adult BALB/c mice 
infected during adulthood with L. (L) mexicana. Footpad thick-
ness of neonatal mice infected with 5 × 105 promastigotes 
(■ ); neonatal mice transferred with 1 × 106 (❍ ;), 1 × 105 () 
and 1 × 103 () DCs and subsequently infected with 5 × 105 
promastigotes.
Progression of the infection in neonatal recipient BALB/c  mice after adoptive transfer of DCs from adult BALB/c mice  infected during neonatal life with L. (L) mexicana Figure 4
Progression of the infection in neonatal recipient BALB/c 
mice after adoptive transfer of DCs from adult BALB/c mice 
infected during neonatal life with L. (L) mexicana. Footpad 
thickness of neonatal mice infected with 5 × 105 promastig-
otes (■ ); neonatal mice transferred with 1 × 106 (❍ ) and 1 × 
105 () DCs and subsequently infected with 5 × 105 promas-
tigotes.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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a very striking result since only Dadaglio et al.[39] have
shown that neonatal DCs are as effective as adult DCs in
expressing MHC and costimulatory molecules; taking-up,
processing and presenting antigens to T cells inducing CTL
responses in vivo. Others have shown that neonatal DCs
are not fully functional [40,41]. Also, animals receiving
DCs from healthy adult mice showed a slightly but signif-
icantly reduced protection from that observed with DCs
from adult mice infected during adulthood and healthy
neonatal mice. Various studies have shown that epider-
mal DCs in aged skin are reduced significantly compared
with young skin in mice and humans [42-48]. This cellu-
lar reduction may be the consequence of a decreased pro-
duction in the bone marrow of DC progenitors or
alternatively, these stem cells may be less responsive to
cytokine and chemokine signals required for their homing
to the skin [49-51]. Our results favor the latter hypothesis,
since the same numbers of transferred DCs from healthy
neonatal or adult mice induced a somewhat different dis-
ease outcome. More notable was the observed absence of
a protective effect in mice receiving DCs from adult BALB/
c mice infected with L. (L) mexicana during neonatal life.
This result confirmed recent studies by Adkins et al. show-
ing that animals initially immunized as neonates are una-
ble to develop the expected Th1 memory effector function
observed in adults [9]. These investigators proposed that
in neonates, the spleen is the primary site of tolerance
induction to self-antigens whereas the lymph nodes are
the sites of immune responsiveness to foreign antigens.
The initial and transitory protection observed at the
greatest concentration of DCs from adult mice infected
during neonatal period, suggests impairment in their
accessory functions specifically in those associated with
signal 2 and signal 3. Signal 2 comprises co-stimulatory
factors essential for the clonal expansion of T cells and sig-
nal 3 involves in situ properties of DCs such as tissue
interaction and migration where cytokines, chemokines
and extracellular matrix components are crucial [36].
Conclusions
Our results show that tolerizing DCs from animals ini-
tially immunized as neonates play a key role in the
attenuation of Th1 responses. The present results may
have a considerable epidemiological impact on leishma-
niasis, where infection at early stages of life may impose a
tolerogenic state that favors the development of visceral or
diffuse cutaneous leishmaniasis, both characterized by
Th2-type responses.
Progression of the infection in neonatal recipient BALB/c  mice after adoptive transfer of DCs from healthy adult BALB/ c mice Figure 5
Progression of the infection in neonatal recipient BALB/c 
mice after adoptive transfer of DCs from healthy adult BALB/
c mice. Footpad thickness of neonatal mice infected with 5 × 
105 promastigotes (■ ); neonatal mice transferred with 1 × 
105 (❍ ) and 1 × 106 () DCs and subsequently infected with 
5 × 105 promastigotes.
Progression of the infection in neonatal recipient BALB/c  mice after adoptive transfer of DCs from healthy neonatal  BALB/c mice Figure 6
Progression of the infection in neonatal recipient BALB/c 
mice after adoptive transfer of DCs from healthy neonatal 
BALB/c mice. Footpad thickness of neonatal mice infected 
with 5 × 105 promastigotes (■ ); neonatal mice transferred 
with 1 × 105 () and 1 × 103 () DCs and subsequently 
infected with 5 × 105 promastigotes.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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In this study, we have shown that intraperitoneal adoptive
transfer of splenic DCs is able to surpass the genetic bias
of the mice, allowing the development of an immune




Adult (6 weeks) and neonatal (about 24 hour newborn)
female BALB/c mice (Taconic, Germantown, NY, U.S.A.)
were raised in the Animal House of the Instituto de Bio-
medicina, under appropriate conditions of temperature,
water and feeding.
Specific Antibodies
The following rat monoclonal antibodies were used to
isolate and characterize dendritic cells: CD19 (B cells,
clone IBL-2), MOMA-2 (Macrophages/Monocytes),
CD45R (B and NK cells; clone RA3-6B2), CD3 (T cells;
clone KT3), CD11c (dendritic cells and other leukocytes,
clone N418), CD19 (clone 6D5) conjugated to phycoeri-
trine (PE), NK1.1 (clone PK136) conjugated to PE,
Macrophages-Monocytes (MOMA-2) conjugated to fluo-
rescein isothiocyanate (FITC), CD3 (clone KT3) conju-
gated to FITC. All were purchased from Serotec Ltd.
(Oxford, United Kingdom) except CD205 (dendritic cells,
clone NLDC-145, DEC205) donated by Georg Kraal, Vrije
Universiteit, Amsterdam, The Netherlands; I-Ad (MHC-II,
clone AMS-32.1) and CD86 (B7.2, clone GL1) purchased
from BD Pharmigen (San Diego, USA).
Parasite culture and isolation of L. (L.) mexicana 
promastigotes
Amastigotes of Leishmania (Leishmania) mexicana
(MHOM/BZ/82/BEL21) were extracted from footpad
nodules of hamsters infected a month earlier with 1 × 106
amastigotes. The nodules were aseptically dissected out
and washed in phosphate-buffered saline (PBS, pH 7.4)
with 100 U/ml penicillin and 100 µg/ml streptomycin,
and finely cut and ground in a Petri dish containing cold
PBS. The suspension was filtered through a sterile sieve to
remove large debris. These parasites were cultured on
blood agar base (Sigma-Aldrich, St. Louis, U.S.A.) at room
temperature for 7 days (the stationary growth phase) to
obtain infective promastigotes. For an enriched popula-
tion of parasites, free of erythrocytes and cellular debris,
100 µl of that sample were cultured in 2 ml Schneider's
insect cell culture medium (Sigma-Aldrich, St. Louis,
U.S.A.) for one week at room temperature. Promastigotes
were isolated after 3 washes with sterile PBS and
centrifugation at 1000 g at 4°C for 15 min. Pellets were
resuspended in 1 ml of sterile PBS. Viable parasites were
counted by trypan blue exclusion. Parasite concentration
was adjusted to 5 × 104, 1 × 105, 2 × 105 and 5 × 105 per µl
to be used in the different experimental groups.
Experimental infection with promastigotes of L. (L.) 
mexicana
A similar pattern of L. (L.) mexicana infection to that
established in adult mice [52] was determined in neonatal
BALB/c mice. Neonatal BALB/c mice (n = 12) were inocu-
lated subcutaneouslly into the left hind footpad with 5 ×
104, 1 × 105, 2 × 105, or 5 × 105 promastigotes suspended
in 10 µl sterile PBS, applied with a tuberculin syringe (29-
gauge needle) connected to a stepper repetitive pipette
(Tridak, Danbury, U.S.A.). For comparison, adult BALB/c
mice were infected the standardized optimal parasite load
of 1 × 106 promastigotes of L. (L.) mexicana [52]. The
course of infection was evaluated weekly for 6 weeks,
measuring the experimental left footpad using a dial
gauge caliper (Mituyoto N° 7300, U.S.A.).
Isolation and purification of dendritic cells
DCs from adult and neonatal BALB/c mice were isolated
from the spleen. Under sterile conditions, spleens were
minced on a metallic mesh with RPMI-1640 (Life Tech-
nologies, Rockville, U.S.A.) supplemented with 10% of
decomplemented fetal bovine serum (FBS), 2 mM L-
Progression of the infection in neonatal recipient BALB/c  mice after the adoptive transfer of DCs from the different  experimental groups Figure 7
Progression of the infection in neonatal recipient BALB/c 
mice after the adoptive transfer of DCs from the different 
experimental groups. Footpad thickness of neonatal mice 
infected with 5 × 105 promastigotes (■ ); neonatal mice trans-
ferred with 1 × 106 DCs from adult BALB/c mice infected 
during adulthood (), adult BALB/c mice infected during 
neonatal life (❍ ), healthy adult BALB/c mice (● ) and 1 × 105 
CDs from healthy neonatal BALB/c mice () and subse-
quently infected with 5 × 105 promastigotes.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 50 µM
2-mercaptoethanol and 100 U/ml penicillin (complete
RPMI-10). The cell suspension was filtered on a nylon
sieve and transferred to 15 ml centrifuge tubes (Corning
Life Sciences, Acton, U.S.A.) and spun at 250 g at 4°C for
10 min. Viable cells were counted by trypan blue exclu-
sion. Cell concentration was adjusted to 1 × 107 cells/ml
in complete RPMI-10 and 8 ml plated in tissue culture
flasks. The flaks were incubated for 2 hr at 37°C in a 5%
CO2 incubator (NuAire, Inc., Plymouth, U.S.A.), allowing
DCs to adhere. Non adherent cells were carefully removed
and placed in sterile 50 ml centrifuge tubes and spun at
250 g, 4°C for 10 min. Adherent cells were covered with
10 ml complete RPMI-10 and incubated as before for 16–
18 hours, allowing DCs to detach. After gently washing
the surface of the flasks with a plugged Pasteur pipette and
complete RPMI-10, pools of the eluted cells were placed
in sterile 15 ml centrifuge tubes and spun at 250 g, 4°C for
10 min. For each tube, the cell pellet was resuspended in
6 ml complete RPMI-10. This volume was carefully lay-
ered over a 3 ml NycoPrep™ density gradient (Nycomed
Pharma AS, Torshov, Norway) and centrifuged at 600 g,
20°C for 20 min. Mononuclear cells were removed from
the interface ring using a Pasteur pipette, transferred to a
sterile 15 ml centrifuge tube and spun down in 10 ml
complete RPMI-10 at 400 g, 20°C for 15 min three times.
The final pellet was resuspended in 1 ml of cold (4°C)
Hanks balanced salt solution supplemented with 10%
decomplemented FBS and 2 mM HEPES. Cells were quan-
tified and viability assessed by trypan blue exclusion.
The final purification stage consisted of an immunomag-
netic negative selection of DCs. The cell suspension
obtained above was incubated under continuous agita-
tion at 4°C for 1 hour, with primary rat anti-mouse mon-
oclonal antibodies recognizing B and T lymphocytes, NK
cells and monocytes/macrophages (1.5 µg/ml antibody
per 1 × 106 cells). After incubation, cells were washed
three times in Hanks centrifuging at 250 g, 4°C for 10
min. The pellet was resuspended in 1 ml cold Hanks in a
sterile 15 ml centrifuge tube and incubated under contin-
uous agitation at 4°C for 1 hour with a secondary sheep
anti-rat IgG polyclonal antibody coupled to magnetic
microspheres (Dynabeads® M-450, Dynal Biotech Inc.,
Lake Success, U.S.A.) at a 7:1 sphere/target ratio. Non-
dendritic magnetic-coated cells were removed by positive
selection in three sequential depletions using a magnetic
gadget (Dynal MPC® Dynal Biotech Inc., Lake Success,
U.S.A.) at 4°C for 6 min.
Characterization of dendritic cells
DC purity was determined by flow cytometry and immu-
nocytochemistry. For flow cytometry, 1 × 105 cells were
suspended in PBS (1% FBS) and incubated with 10 µl pri-
mary monoclonal antibodies directly coupled to PE or
FITC recognizing T and B lymphocytes, NK cells and
monocytes/macrophages. DCs were characterized by an
indirect method using primary monoclonal antibodies to
CD11c and a secondary antibody, hamster anti-rat
IgG1conjugated to FITC (clone MARG1-2, Serotec Ltd.,
Oxford, United Kingdom). The incubations were carried
out in the dark at 4°C for 45 min, followed by 3 washes
and centrifugation at 250 g, 4°C for 10 min. The cell pellet
was resuspended in 500 µl PBS and the percentage of
labeled cells determined in a flow cytometer (FACScan,
Becton Dickinson, Franklin Lakes, U.S.A.). The control
consisted of an antibody of irrelevant specificity conju-
gated to FITC.
For immunocytochemistry, 1 × 105 cells were suspended
in PBS (1% FBS) and spun down at 50 g in a Cytospin
(Shandon Inc., Pittsburg, U.S.A.). Sample slides were
hydrated in PBS, fixed in fresh acetone for 5 min. and
sequentially incubated for 90 min with primary rat mon-
oclonal antibodies to CD11c and CD205, biotinylated
goat anti-rat IgG (50 µg/ml) (Vector Laboratories, Burlin-
game, U.S.A.) for 45 min., and Vectastain® Elite ABC kit
(Vector Laboratories, Burlingame, U.S.A.) at 1:100, 30
min. Five-minute washes with PBS were done between
incubations. The reactions were developed for 3 minutes
in Vector®  NovaRed™ substrate. The slides were then
washed and counterstained with methyl green. Omissions
of the primary antibody and incubation with an antibody
of irrelevant specificity at the same protein concentration
were used as controls.
Adoptive transfer of dendritic cells
DCs were isolated from the spleens of the following
donor groups: a) Adult BALB/c mice infected during
adulthood with L. (L.). mexicana (n = 4); b) Adult BALB/c
mice infected during neonatal life with L. (L.). mexicana
(n = 4); c) Healthy neonatal BALB/c mice (n = 4); d)
Healthy adult BALB/c mice (n = 4). The infection control
group consisted of neonatal BALB/c mice infected with 5
× 105 promastigotes of L. (L) mexicana.
DCs from the 4 experimental groups were adjusted to 1 ×
103, 1 × 105, or 1 × 106 cells/ml in sterile PBS for intraperi-
toneal transfer to neonatal recipient BALB/c mice. Cells, at
the mentioned concentrations, were injected in 20 µl vol-
umes using a tuberculin syringe (29-gauge needle)
connected to a stepper repetitive pipette (Tridak, Dan-
bury, U.S.A.). After sixteen hours of adoptive transfer,
neonatal recipient BALB/c mice were infected with 5 × 105
promastigotes of L. (L) mexicana.
Isolation of DCs and adoptive transfer experiments were
done in duplicates.Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
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Statistical analysis
The results were expressed as mean ± standard error of the
mean (SEM). Each experimental group consisted of 4–5
individuals. Comparisons between groups were made
with Student t test and Welch t test for unpaired samples.
Any value of p ≤ 0.05 was considered significant. All tests
were performed using GraphPad InStat 3.02 (GraphPad







The author(s) declare that they have no competing
interests.
Authors' contributions
LVP carried out most of the experimental work and
drafted the manuscript. JC developed the experimental
design, carried out part of the experimental work and
drafted the manuscript. NLD participated in the in exper-
imental design and evaluated the progression of infection
in the mice. FJT conceived the study, participated in the
experimental design and coordinated the work. All
authors read and approved the final manuscript.
Acknowledgements
We are grateful to Becky Adkins for insightful discussions and critical 
appraisal of the manuscript; Marian Ulrich for reading and commenting on 
the manuscript; Martin A. Sanchez for excellent scientific consultation on 
the flow cytometry information. We would like to acknowledge the per-
sonnel from the Animal House of the Instituto de Biomedicina and the Flow 
Cytometry Facility of Banco Municipal de Sangre in Caracas. This work was 
supported by Fondo Nacional de Ciencia, Tecnología e Innovación 
(FONACIT) Proyecto S1- 98000041 and Millennium Scientific Initiative 
Grant 4572VE, UNDP/World Bank/WHO Special Programme for 
Research and Training in Tropical Diseases, European Commission INCO 
Programme, and CDCH- Universidad Central de Venezuela.
References
1. Billingham RE, Brent L, Medawar BP: Quantitative studies of tis-
sue transplantation immunity.  Proc R Soc Lond Biol Sci 1956,
239:44.
2. Matzinger P: The danger model: a renewed sense of self. Science
2002, 296:301-305.
3. Anderson CC, Carroll JM, Gallucci S, Ridge JP, Cheever AW, Matz-
inger P: Testing time-, ignorance-, and danger-based models
of tolerance. J Immunol 2001, 166:3663-3671.
4. Singh RR, Hahn BH, Sercarz EE: Neonatal peptide exposure can
prime T cells and, upon subsequent immunization, induce
their immune deviation: implications for antibody vs. T cell-
mediated autoimmunity. J Exp Med 1996, 183:1613-1621.
5. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited:
turning on newborn T cells with dendritic cells. Science 1996,
271:1723-1726.
6. Adkins B, Bu Y, Cepero E, Perez R: Exclusive Th2 primary effec-
tor function in spleens but mixed Th1/Th2 function in lymph
nodes of murine neonates. J Immunol 2000, 164:2347-2353.
7. Adkins B: T-cell function in newborn mice and humans. Immu-
nol Today 1999, 20:330-335.
8. Adkins B, Ghanei A, Hamilton K: Up-regulation of murine neona-
tal T helper cell responses by accessory cell factors. J Immunol
1994, 153:3378-3385.
9. Adkins B, Bu Y, Guevara P: The generation of Th memory in
neonates versus adults: prolonged primary Th2 effector
function and impaired development of Th1 memory effector
function in murine neonates. J Immunol 2001, 166:918-925.
10. Forsthuber T, Yip HC, Lehmann PV: Induction of TH1 and TH2
immunity in neonatal mice. Science 1996, 271:1728-1730.
11. Sarzotti M, Robbins DS, Hoffman PM: Induction of protective
CTL responses in newborn mice by a murine retrovirus. Sci-
ence 1996, 271:1726-1728.
12. Bot A: DNA vaccination and the immune responsiveness of
neonates. Int Rev Immunol 2000, 19:221-245.
13. Garza KM, Griggs ND, Tung KS: Neonatal injection of an ovarian
peptide induces autoimmune ovarian disease in female
mice: requirement of endogenous neonatal ovaries. Immunity
1997, 6:89-96.
14. Matzinger P: Essay 1: the Danger model in its historical
context. Scandinavian Journal of Immunology 2001, 54:4-9.
15. Diaz NL, Fernandez M, Figueira E, Ramirez R, Monsalve IB, Tapia FJ:
Nitric oxide and cellular immunity in experimental cutane-
ous leishmaniasis. Clin Exp Dermatol 2003, 28:288-293.
16. Perez H, Arredondo B, Gonzalez M: Comparative study of Amer-
ican cutaneous leishmaniasis and diffuse cutaneous leishma-
niasis in two strains of inbred mice.  Infect Immun 1978,
22:301-307.
17. Perez H, Arredondo B, Machado R: Leishmania mexicana and
Leishmania tropica: cross immunity in C57BL/6 mice. Exp
Parasitol 1979, 48:9-14.
18. Moll H, Fuchs H, Blank C, Rollinghoff M: Langerhans cells trans-
port Leishmania major from the infected skin to the draining
lymph node for presentation to antigen-specific T cells. Eur J
Immunol 1993, 23:1595-1601.
19. Modlin RL, Tapia FJ, Bloom BR, Gallinoto ME, Castes M, Rondon AJ,
Rea TH, Convit J: In situ characterization of the cellular
immune response in American cutaneous leishmaniasis. Clin
Exp Immunol 1985, 60:241-248.
20. Tapia FJ, Rojas E, Kraal G, Mosca W, Convit J: Immunocytochem-
ical analysis of Langerhans cells in murine cutaneous leish-
maniasis. In The Langerhans Cell Volume 172. Edited by: Thivolet J,
Schmitt D. Colloques INSERM/John Libbey Eurotext Ltd;
1988:479-489. 
21. Caceres-Dittmar G, Sanchez MA, Oriol O, Kraal G, Tapia FJ: Epider-
mal compromise in American cutaneous leishmaniasis.  J
Invest Dermatol 1992, 99:95S-98S.
22. Sanchez MA, Caceres-Dittmar G, Oriol O, Mosca W, Kraal G, Tapia
FJ:  Epidermal Langerhans cells and dendritic epidermal T
cells in murine cutaneous leishmaniasis. Immunocytochemi-
cal study. Acta Microscopica 1993, 2:180-187.
23. von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC: Uptake of
Leishmania major amastigotes results in activation and
interleukin 12 release from murine skin-derived dendritic
cells: implications for the initiation of anti-Leishmania
immunity. J Exp Med 1998, 188:1547-1552.
24. Baldwin T, Henri S, Curtis J, O'Keeffe M, Vremec D, Shortman K,
Handman E: Dendritic Cell Populations in Leishmania major-
Infected Skin and Draining Lymph Nodes. Infection and Immunity
2004, 72:1991-2001.
25. Moll H, Flohe S, Rollinghoff M: Dendritic cells in Leishmania
major-immune mice harbor persistent parasites and medi-
ate an antigen-specific T cell immune response. Eur J Immunol
1995, 25:693-699.
26. Brown DH, Lafuse WP, Zwilling BS: Host resistance to mycobac-
teria is compromised by activation of the hypothalamic-pitu-
itary-adrenal axis. Ann N Y Acad Sci 1998, 840:773-786.
27. Chatelain R, Varkila K, Coffman RL: IL-4 induces a Th2 response
in Leishmania major-infected mice.  J Immunol 1992,
148:1182-1187.
28. Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA: In suscep-
tible mice, Leishmania major induce very rapid interleukin-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Kinetoplastid Biology and Disease 2005, 4:2 http://www.kinetoplastids.com/content/4/1/2
Page 9 of 9
(page number not for citation purposes)
4 production by CD4+ T cells which are NK1.1. Eur J Immunol
1995, 25:3298-3307.
29. Launois P, Swihart KG, Milon G, Louis JA: Early production of IL-
4 in susceptible mice infected with Leishmania major rapidly
induces IL-12 unresponsiveness. J Immunol 1997, 158:3317-3324.
30. Elloso MM, Scott P: Expression and contribution of B7-1
(CD80) and B7-2 (CD86) in the early immune response to
Leishmania major infection. J Immunol 1999, 162:6708-6715.
31. Brown JA, Greenwald RJ, Scott S, Schweitzer AN, Satoskar AR,
Chung C, Schopf LR, van der Woude D, Sypek JP, Sharpe AH: T
helper differentiation in resistant and susceptible B7-defi-
cient mice infected with Leishmania major. Eur J Immunol 2002,
32:1764-1772.
32. Adkins B, Hamilton K: Freshly isolated, murine neonatal T cells
produce IL-4 in response to anti-CD3 stimulation. J Immunol
1992, 149:3448-3455.
33. Adkins B, Ghanei A, Hamilton K: Developmental regulation of
IL-4, IL-2, and IFN-gamma production by murine peripheral
T lymphocytes. J Immunol 1993, 151:6617-6626.
34. Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells
pulsed with protein antigens in vitro can prime antigen-spe-
cific, MHC-restricted T cells in situ.  J Exp Med 1990,
172:631-640.
35. Boog CJ, Kast WM, Timmers HT, Boes J, de Waal LP, Melief CJ: Abo-
lition of specific immune response defect by immunization
with dendritic cells. Nature 1985, 318:59-62.
36. Steinman RM, Inaba H, Schuler G: Cutaneous dendritic cells: Dis-
tinctive antigen-presenting cells for experimental models
and disease states. In The immune functions of Epidermal Langerhans
cells Edited by: Moll H. RG Landes Co; 1995:1-19. 
37. Schuler G, Lutz M, Bender A, Thurner B, Röder C, Young JW, Romani
N: A guide to the isolation and propagation of dendritic cells.
In Dendritic Cells. Biology and Clinical Applications Edited by: Lotze M.
Thomson AW: Academic Press; 1999:515-533. 
38. Moll H, Berberich C: Dendritic cell-based vaccination strate-
gies: induction of protective immunity against leishmaniasis.
Immunobiology 2001, 204:659-666.
39. Dadaglio G, Sun C-M, Lo-Man R, Siegrist CA, Leclerc C: Efficient In
Vivo Priming of Specific Cytotoxic T Cell Responses by Neo-
natal Dendritic Cells. J Immunol 2002, 168:2219-2224.
40. Muthukkumar S, Goldstein J, Stein KE: The ability of B cells and
dendritic cells to present antigen increases during ontogeny.
J Immunol 2000, 165:4803-4813.
41. Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, Goldman M,
De Wit D: Deficient IL-12(p35) Gene Expression by Dendritic
Cells Derived from Neonatal Monocytes.  J Immunol 2001,
166:2141-2146.
42. Schwartz JL, Weichselbaum R, Frim SR: The effect of aging on the
density and distribution of oral mucosal Langerhans cells. Exp
Gerontol 1983, 18:65-71.
43. Rittman BR, Hill MW, Rittman GA, Mackenzie IC: Age-associated
changes in Langerhans cells of murine oral epithelium and
epidermis. Arch Oral Biol 1987, 32:885-889.
44. Choi KL, Sauder DN: Epidermal Langerhans cell density and
contact sensitivity in young and aged BALB/c mice. Mech Age-
ing Dev 1987, 39:69-79.
45. Sprecher E, Becker Y, Kraal G, Hall E, Harrison D, Shultz LD: Effect
of aging on epidermal dendritic cell populations in C57BL/6J
mice. J Invest Dermatol 1990, 94:247-253.
46. Gilchrest BA, Murphy GF, Soter NA: Effect of chronologic aging
and ultraviolet irradiation on Langerhans cells in human
epidermis. J Invest Dermatol 1982, 79:85-88.
47. Thiers BH, Maize JC, Spicer SS, Cantor AB: The effect of aging and
chronic sun exposure on human Langerhans cell
populations. J Invest Dermatol 1984, 82:223-226.
48. Scheibner A, McCarthy WH, Milton GW, Nordlund JJ: Langerhans
cell and melanocyte distribution in "normal" human epider-
mis. Preliminary report. Australas J Dermatol 1983, 24:9-16.
49. Buchanan JP, Peters CA, Rasmussen CJ, Rothstein G: Impaired
expression of hematopoietic growth factors: a candidate
mechanism for the hematopoietic defect of aging. Exp Gerontol
1996, 31:135-144.
50. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM:
Granulocyte/macrophage colony-stimulating factor is essen-
tial for the viability and function of cultured murine epider-
mal Langerhans cells. J Exp Med 1987, 166:1484-1498.
51. Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I,
Griffiths CE: Tumour necrosis factor-alpha-induced migration
of human Langerhans cells: the influence of ageing.  Br J
Dermatol 2002, 146:32-40.
52. Perez H, Labrador F, Torrealba JW: Variations in the response of
five strains of mice to Leishmania mexicana. Int J Parasitol 1979,
9:27-32.